BillionToOne
We push the boundaries of molecular diagnostics through quantitative technologies.
815 employees · est. 2016 · Menlo Park, United States
QuantumCyte, Inc. is the older company (2016 vs 2013); BillionToOne is the larger of the two.
Side-by-Side Comparison
| Metric | BillionToOne | QuantumCyte, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2013 older |
| Headquarters | ||
| Headquarters | Menlo Park, United States | Fremont, United States |
| Employees | ||
| Employees | 815 larger | 15 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Life Sciences |
| Funding Stage | ||
| Funding Stage | IPO | Unknown |
| Total Funding | ||
| Total Funding | $650.63M | $1.05M |
| Funding Rounds | ||
| Funding Rounds | 9 | 6 |
| Services | ||
| Services | Development and provision of advanced diagnostic tests, Quantification of disease-causing DNA fragments, Non-invasive prenatal and oncology testing solutions, Monitoring treatment response in cancer patients | Tissue slide transformation, High-purity molecular sampling, Integrated precision diagnostics, AI-powered pathology integration |
| Target Customers | ||
| Target Customers | Healthcare Providers, Pregnant Women, Oncologists, Medical Researchers | Research Labs, Clinical Labs, Pharmaceutical Companies, Precision Medicine Innovators, Healthcare Providers |
| Taxonomy | ||
| Taxonomy | Molecular Diagnostics, Precision Diagnostics, DNA Quantification, Molecular Counting Technology, Disease Detection, Prenatal Testing, Single-gene Disorder Detection, Non-invasive Testing, Blood Test Innovation, Affordable Healthcare Solutions, Patent-pending Technology, Risk Reduction In Diagnostics, Biotechnology Innovation | NextGen Microdissection Platform, Technology Platform Company, In-situ Lysis, Automated Tissue Dissection System, Digital Tissue Maps, ROIs, Informative Biomarkers, Precision Medicine, Biopharma, NGS, Molecular Pathology, Clinical Diagnostics, Spatial Profiling |
| Website | ||
| Website | billiontoone.com | quantumcyte.com |
About BillionToOne
BillionToOne, founded in 2016, is a pioneering entity in the Biotechnology and Health Care industries, headquartered in the United States. The company is renowned for its commitment to enhancing the accuracy, efficiency, and accessibility of molecular diagnostics, encapsulated in their slogan: "We p...
About QuantumCyte, Inc.
QuantumCyte, Inc., founded in 2013, is a transformative player in the Biotechnology and Life Sciences industries, headquartered in the United States. Their innovative approach bridges the gap between digital pathology, spatial biology, and molecular testing, promising to convert every biopsy into a...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at BillionToOne and QuantumCyte, Inc. — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at BillionToOne and QuantumCyte, Inc. — by email.
Frequently Asked Questions
Compare BillionToOne with someone else
Start typing a company name or domain.